About Maria L. Maccecchini

I have devoted my life and 30-year career to the study of neurodegenerative diseases and their possible treatments. My experience in biotechnology, the pharmaceutical industry, healthcare, and biomedical research provides a foundation for addressing complex problems in life sciences focused on the development of breakthrough therapies.

Presently, I am founder and CEO of Annovis, my second biotechnology company, having sold the first one. Annovis is a clinical-stage specialty pharmaceutical company committed to developing therapeutics with novel approaches for the treatment of cognitive impairment, Alzheimer’s disease (AD), Parkinson’s disease (PD) and Down syndrome (DS).

The knowledge gained studying neurodegenerative diseases has enabled me to successfully attract capital, spur innovation, lead new product development and commercialization, scale operations, efficiently fulfill compliance regulations, and essentially lead biotechnology organizations.

As a result of my extensive experience as a public and private company Board member; as an Executive Officer, and as a member of Scientific Advisory Committees, I have become skilled at investor and scientific communications. Speak and write four languages – English, German, Italian and French.

Specialties: Leadership, General Management, Business Development, Licensing, Mergers and Acquisitions, R&D, Regulatory, Commercial, Strategic Planning